Insufficient scRNA-seq data for expression of GBP6 at single-cell level.
Insufficient scRNA-seq data for expression of GBP6 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 65% | 15720.28 | 933 / 1445 | 62% | 92.82 | 114 / 183 |
lung | 77% | 40.52 | 443 / 578 | 50% | 34.98 | 578 / 1155 |
uterus | 64% | 147.29 | 108 / 170 | 53% | 42.04 | 242 / 459 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.08 | 1 / 1 |
tonsil | 0% | 0 | 0 / 0 | 98% | 135.11 | 44 / 45 |
bladder | 62% | 23.24 | 13 / 21 | 34% | 8.83 | 173 / 504 |
spleen | 89% | 18.22 | 214 / 241 | 0% | 0 | 0 / 0 |
ovary | 87% | 30.31 | 156 / 180 | 0% | 0.02 | 2 / 430 |
skin | 73% | 58.93 | 1321 / 1809 | 11% | 0.68 | 50 / 472 |
thymus | 63% | 15.83 | 414 / 653 | 8% | 0.60 | 47 / 605 |
peripheral blood | 71% | 32.53 | 655 / 929 | 0% | 0 | 0 / 0 |
breast | 58% | 15.16 | 265 / 459 | 7% | 0.46 | 77 / 1118 |
brain | 61% | 12.27 | 1620 / 2642 | 2% | 0.07 | 14 / 705 |
prostate | 60% | 11.68 | 146 / 245 | 0% | 0 | 0 / 502 |
pancreas | 45% | 8.17 | 148 / 328 | 10% | 0.57 | 17 / 178 |
liver | 48% | 7.25 | 108 / 226 | 1% | 0.03 | 3 / 406 |
stomach | 44% | 59.54 | 158 / 359 | 3% | 0.13 | 10 / 286 |
muscle | 45% | 24.75 | 358 / 803 | 0% | 0 | 0 / 0 |
adrenal gland | 40% | 6.49 | 104 / 258 | 0% | 0.02 | 1 / 230 |
intestine | 34% | 5.95 | 330 / 966 | 5% | 4.97 | 26 / 527 |
kidney | 31% | 5.10 | 28 / 89 | 0% | 0.02 | 4 / 901 |
blood vessel | 30% | 5.62 | 398 / 1335 | 0% | 0 | 0 / 0 |
adipose | 29% | 7.16 | 354 / 1204 | 0% | 0 | 0 / 0 |
heart | 28% | 3.65 | 238 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.43 | 1 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006955 | Biological process | immune response |
GO_0050830 | Biological process | defense response to Gram-positive bacterium |
GO_0042832 | Biological process | defense response to protozoan |
GO_0042742 | Biological process | defense response to bacterium |
GO_0071346 | Biological process | cellular response to type II interferon |
GO_0070062 | Cellular component | extracellular exosome |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0005525 | Molecular function | GTP binding |
GO_0003924 | Molecular function | GTPase activity |
Gene name | GBP6 |
Protein name | Guanylate-binding protein 6 (EC 3.6.5.-) (GTP-binding protein 6) (GBP-6) (Guanine nucleotide-binding protein 6) |
Synonyms | |
Description | FUNCTION: Interferon (IFN)-inducible GTPase that plays important roles in innate immunity against a diverse range of bacterial, viral and protozoan pathogens, such as bacterial pathogens Listeria monocytogenes and Mycobacterium bovis BCG as well as the protozoan pathogen Toxoplasma gondii (By similarity). Confers protection to several pathogens, including the bacterial pathogens Listeria monocytogenes and Mycobacterium bovis BCG as well as the protozoan pathogen Toxoplasma gondii (By similarity). . |
Accessions | Q6ZN66 ENST00000370456.5 [Q6ZN66-1] |